Gyre Therapeutics, Inc. Common Stock

GYRENASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
6.29 USD
↗ 0.10 (1.62%)AT CLOSE (11:59 AM EDT)
6.28
↘ 0.01 (0.16%)
POST MARKET (AS OF 07:17 PM EDT)
Post Market
AS OF 07:17 PM EDT
6.28
↘ 0.01 (0.16%)
🔴Market: CLOSED
Open?$6.20
High?$6.66
Low?$6.13
Prev. Close?$6.19
Volume?137.9K
Avg. Volume?89.2K
VWAP?$6.38
Rel. Volume?1.55x
Bid / Ask
Bid?$6.28 × 100
Ask?$6.33 × 100
Spread?$0.05
Midpoint?$6.31
Valuation & Ratios
Market Cap?610.3M
Shares Out?97.0M
Float?17.8M
Float %?18.4%
P/E Ratio?N/A
P/B Ratio?6.02
EPS?-$0.07
Dividend?0.00%
Ex-Dividend?N/A

Shares of Gyre Therapeutics, Inc. Common Stock (GYRE) are trading at $6.29. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, GYRE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Themes
Biotech - Drug Development›Metabolic & Cardiometabolic
Employees
618
Market Cap
610.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.gyretx.com
Listed
2023-10-31
Address
12730 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: (858) 284-0115
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
20
Short Sent.?
43
Piotroski F-Score?2/9Weak
Altman Z-Score?15.21Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.39%Elevated
Short Interest?1.7M
Days to Cover?18.2
Free Float17.8M
Avg Daily Volume92.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.64Strong
Quick Ratio?4.06Strong
Cash Ratio?1.90Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
53/100
P/E?
N/A▾
P/B?
Peers
100
S&P
30
6.02FAIR▾
P/S?
Peers
100
S&P
28
5.21FAIR▾
P/FCF?
Peers
100
S&P
3
198.6PRICEY▾
EV/EBITDA?
Peers
100
S&P
3
227.3HIGH▾
EV/Sales?
Peers
100
S&P
37
4.89FAIR▾
Returns & Efficiency
ROE?
S&P
10
-6.3%WEAK▾
ROA?
S&P
3
-3.9%WEAK▾
Cash Flow & Enterprise
FCF?$3.1M
Enterprise Value?$572.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist